Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections

被引：15
|
作者：
Claros, Marina [1 ]
Citron, Diane M. [2 ]
Goldstein, Ellie J. C. [2 ,3 ]
Merriam, C. Vreni [2 ]
Tyrrell, Kerin L. [2 ]
机构：
[1] Roche Diagnost Int AG, Rotkreuz, Switzerland
[2] R M Alden Res Lab, Culver City, CA 90230 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2013年 / 76卷 / 04期
关键词：
Anaerobes; Diabetic foot infection; Intra-abdominal infection; Resistance; Finegoldia magna; Bacteroides fragilis; Levofloxacin; Ertapenem; CARBAPENEMS; RESISTANCE;
D O I：
10.1016/j.diagmicrobio.2013.04.025
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Few labs isolate and perform susceptibility tests on anaerobes; therefore, we studied the differences between 1185 anaerobes isolated from complicated intra-abdominal infections and 470 isolated from moderate to severe diabetic foot infections. They differed markedly in the distribution of species, including Bacteroides fragilis and anaerobic Gram-positive cocci, as well as in resistance patterns, especially to fluoroquinolones. (c) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：546 / 548
页数：3
相关论文
共 50 条
  • [11] Duration of antimicrobial therapy for intra-abdominal infections
    Hedrick, TL
    Sawyer, RG
    INFECTIONS IN MEDICINE, 2004, 21 (10) : 506 - 510
  • [12] Efficacy of tigecycline in complicated skin and skin structure infections and complicated intra-abdominal infections
    Wilcox, MH
    JOURNAL OF CHEMOTHERAPY, 2005, 17 : 23 - 29
  • [13] New and Emerging Antibiotics for Complicated Intra-Abdominal Infections
    Durand, Cheryl R.
    Alsharhan, Mohammad
    Willett, Kristine C.
    AMERICAN JOURNAL OF THERAPEUTICS, 2017, 24 (06) : e763 - e769
  • [14] Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia
    Hsueh, Po-Ren
    Hawkey, Peter Michael
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (02) : 129 - 133
  • [15] Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
    Goodlet, Kellie J.
    Nicolau, David P.
    Nailor, Michael D.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 1811 - 1826
  • [16] Essentials for Selecting Antimicrobial Therapy for Intra-Abdominal Infections
    Stijn Blot
    Jan J. De Waele
    Dirk Vogelaers
    Drugs, 2012, 72 : e17 - e32
  • [17] Antimicrobial and surgical management of intra-abdominal infections in children
    Hamilton, Nicholas A.
    Mazuski, John E.
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2009, 4 (01) : 37 - 45
  • [18] Antimicrobial susceptibility changes of Escherichia coli and Klebsiella pneumoniae intra-abdominal infection isolate-derived pathogens from Chinese intra-abdominal infections from 2011 to 2015
    Zhang, Hui
    Tong, Dawei
    Johnson, Aaron
    Zhang, Ge
    Xu, Zhipeng
    Yang, Yang
    Zhang, Jingjia
    Li, Dongxue
    Duan, Simeng
    Wang, Yao
    Yang, Qiwen
    Xu, Yingchun
    INFECTION AND DRUG RESISTANCE, 2019, 12 : 2477 - 2486
  • [19] New advances in the use of antimicrobial agents in surgery: Intra-abdominal infections
    Cinat, ME
    Wilson, SE
    JOURNAL OF CHEMOTHERAPY, 1999, 11 (06) : 453 - 463
  • [20] Complicated Intra-Abdominal Infections: The Old Antimicrobials and the New Players
    Young R. Lee
    Danni McMahan
    Catherine McCall
    Gregory K. Perry
    Drugs, 2015, 75 : 2097 - 2117
12345